Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5214468 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ESIGMAR1NAAAOPRM1 | |
| SCHEMBL6680534 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ESIGMAR1NAAAOPRM1 | |
| SCHEMBL28560209 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ESIGMAR1NAAAOPRM1 | |
| SCHEMBL11545835 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ESIGMAR1NAAAOPRM1 | |
| SCHEMBL6683678 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ESIGMAR1NAAAOPRM1 | |
| SCHEMBL6686368 | 0.98 | SIGMAR1 (0.44) | HTR2ACSNK1ESIGMAR1NAAAOPRM1 | |
| SCHEMBL5034682 | 0.92 | POLB (0.45) | HTR2ASIGMAR1NAAAOPRM1OPRD1 | |
| SCHEMBL3477567 | 0.83 | AOC3 (0.46) | HTR2ASIGMAR1 | |
| SCHEMBL15144138 | 0.83 | HRH1 (0.44) | HTR2ASIGMAR1 | |
| SCHEMBL4740370 | 0.81 | SIGMAR1 (0.62) | HTR2ACSNK1ESIGMAR1NAAACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2428501-B1 | DIARYLIODONIUM SALT MIXTURE AND PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF DIARYLIODONIUM COMPOUND | NIPPON CATALYTIC CHEM IND (JP) | 2018-12-12 | — | — | EP | disclosed |
| US-8975203-B2 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2015-03-10 | — | — | US | disclosed |
| EP-2428501-A1 | DIARYL IODONIUM SALT MIXTURE AND PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF DIARYL IODONIUM COMPOUND | Nippon Shokubai Co., Ltd. (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20120053048-A1 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-03-01 | — | — | US | disclosed |
| EP-0003183-B1 | PROPOXYLATED ETHOXYLATED SURFACTANTS AND METHOD OF RECOVERING OIL THEREWITH | Exxon Production Research Company (US) | 1982-03-31 | — | — | EP | disclosed |
| US-4293428-A | Propoxylated ethoxylated surfactants and method of recovering oil therewith | EXXON PRODUCTION RESEARCH COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
| EP-0003183-A1 | Propoxylated ethoxylated surfactants and method of recovering oil therewith | Exxon Production Research Company (US) | 1979-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053048-A1 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | SPIN4, SALL4, DBF4 | HTR2A 4599/4885CSNK1E 1586/4885SIGMAR1 3881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.